NCT02143843
An Open-Label Extension Study to Evaluate the Safety of the ForSight VISION5 Product treatment 2 completed NCT02792803
A Comparison of Xalatan (Latanoprost) to Apo-latanoprost and Co-latanoprost in the Treatment of Glaucoma treatment 4 unknown_status NCT01162603
Latanoprost Versus Tafluprost: 24-hour Intraocular Pressure (IOP) treatment 4 completed NCT01126203
Randomized Prospective Study of Selective Laser Trabeculoplasty (SLT) Versus Argon Trabeculoplasty (ALT) in Patients With Pseudoexfoliation Glaucoma and Ocular Hypertension No drug interventions treatment 3 completed NCT00465803
A Phase IIIb Study of DuoTrav to Treat Glaucoma or Ocular Hypertension treatment 3 completed NCT00928590
Safety Study of DuoTrav APS in Patients With Open-Angle Glaucoma or Ocular Hypertension treatment 3 completed NCT04944290
To Compare the Efficacy and Safety of Perrigo's Product to an FDA Approved Product for the Treatment of Glaucoma or Ocular Hypertension in Both Eyes treatment 3 completed NCT00950690
Efficacy and Tolerability of Xalatan in Patients Not Available Not Available completed NCT00283764
Safety And Efficacy Of Xalatan Delivered Using Either A Conventional Dropper Bottle or A Delivery Device treatment 3 withdrawn NCT01699464
A Study Assessing the Safety and Ocular Hypotensive Efficacy of AR-12286 in Patients With Elevated Intraocular Pressure for 3 Months treatment 2 completed NCT01943721
A Study of the VISION5 Product in Patients With Glaucoma or Ocular Hypertension No drug interventions prevention 1 completed NCT00465621
Dose Response Study of AL-37807 Ophthalmic Solution in Patients With Open-Angle Glaucoma or Ocular Hypertension treatment 2 completed NCT00838721
Evaluation of Pascal Laser Trabeculoplaty No drug interventions treatment Not Available completed NCT00821002
A Phase 2 Study of Punctal Placement of the Latanoprost Punctal Plug Delivery System (L-PPDS) treatment 2 completed NCT04433702
Effect of Negative Pressure on Pattern Electroretinography Readings No drug interventions prevention Not Available withdrawn NCT02339584
Efficacy and Safety of Brinzolamide/Brimonidine Fixed Combination BID Compared to Brinzolamide BID Plus Brimonidine BID in Subjects With Open-Angle Glaucoma (OAG) or Ocular Hypertension (OHT) treatment 3 completed NCT02858284
Evaluation of Safety and Efficacy of TUG (Therapeutic Ultrasound for Glaucoma) in the Treatment of Primary Open Angle Glaucoma or Ocular Hypertension No drug interventions treatment Not Available terminated NCT05039684
Inflammatory Biomarkers in Ocular Surface in Primary Open Angle Glaucoma or Ocular Hypertension Under Topical Prostaglandins No drug interventions Not Available Not Available recruiting NCT05844384
Nanodropper Use in Primary Open-Angle Glaucoma Patients: A Non-Inferiority Trial No drug interventions other Not Available recruiting NCT00300079
Study of the Intraocular Pressure (IOP)-Lowering Efficacy of Azopt 1.0% Compared to Timolol 0.5% in Patients With Glaucoma or Ocular Hypertension treatment 4 completed NCT01330979
24-hour Efficacy of AR-12286 No drug interventions treatment 2 completed NCT00657579
Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-Angle Glaucoma or Ocular Hypertension No drug interventions Not Available 2 completed NCT04005079
Pilocarpine After Combined Cataract/Trabectome Surgery treatment 3 withdrawn NCT03927443
A Comparative Study of SPARC's SDP-133 Once Daily and Lumigan in Subjects With Open Angle Glaucoma or Ocular Hypertension treatment 3 withdrawn NCT00293787
A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension treatment 3 completed NCT01528787
Study of AR-13324 in Patients With Elevated Intraocular Pressure treatment 2 completed NCT02507687
Comparison of Bimatoprost Sustained Release (SR) to Selective Laser Trabeculoplasty (SLT) in Adults With Open-Angle Glaucoma or Ocular Hypertension treatment 3 completed NCT01312454
Safety and Intraocular Pressure (IOP) Lowering Effect of AL-59412C treatment 2 terminated NCT00912054
DuoTrav APS Versus XALACOM® in Ocular Surface Health treatment 3 terminated NCT00047554
Study of TRAVATAN in Subjects With Iris Pigmentation Changes Not Available Not Available terminated NCT06266351
EVALUATION OF CATS TONOMETER PRISM IN LASIK SUBJECTS No drug interventions Not Available Not Available not_yet_recruiting NCT01646151
A Study Comparing IOP-Lowering Treatments to Bimatoprost in Patients With Primary Open Angle Glaucoma or Ocular Hypertension Not Available Not Available completed NCT00288951
Phase III Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-Angle Glaucoma or Ocular Hypertension Patients No drug interventions treatment 3 completed NCT00159653
A 12-Week, Randomized, Double-Masked, Parallel Group Comparison Of Evening Dosing With Xalacom In Subjects With Glaucoma treatment 3 completed NCT00330577
24-Hour Intraocular Pressure (IOP) And Blood Pressure Control In Glaucoma And Ocular Hypertension Patients treatment 4 completed NCT02003547
A Single Centre Study to Evaluate 3 Ophthalmic Formulations in Healthy Subjects treatment 1 completed NCT02390245
Philadelphia Telemedicine Glaucoma Detection and Follow-Up Study No drug interventions other Not Available completed NCT01510145
Efficacy of Changing to TRAVATAN® From Prior Therapy treatment 4 completed NCT00698945
Comparison of Istalol™ 0.5% QD (Timolol Maleate/Sorbitol Complex, ISTA Pharmaceutical) to Brimonidine Tartrate 0.1% BID as Adjunctive Therapy to Latanoprost 0.005% in Adults With Ocular Hypertension (OHT) or Open-Angle Glaucoma (OAG) treatment 4 completed NCT04609345
Prevalence of Ocular Surface Disease in Malaysian Glaucoma Patients No drug interventions Not Available Not Available unknown_status NCT00803998
Ocular Hypertension Treatment Study (OHTS) No drug interventions Not Available Not Available completed NCT04761705
Safety and Efficacy Study of JV-GL1 in Patients With Open-Angle Glaucoma or Ocular Hypertension treatment 1 / 2 suspended NCT02471105
Investigation of IOP and Tolerability of Bimatoprost 0.01% and Tafluprost Unit Dose Preservative Free 15 Microgram/ml treatment 4 unknown_status NCT01279083
Safety and Efficacy Trial to Treat Open-Angle Glaucoma or Ocular Hypertension treatment 1 / 2 completed NCT04742283
Multicenter Study Assessing the Efficacy and Safety of DE-126 Ophthalmic Solution 0.002% Compared With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension treatment 2 completed NCT00652483
Safety and Efficacy Study of Brimonidine in Patients With Glaucoma or Ocular Hypertension treatment 3 completed NCT01206361
Real World Data Study Assessing The Persistency Of Xalacom And The Other Fixed Dose Combination Products, Duotrav And Ganfort, In The United Kingdom Not Available Not Available completed NCT00293761
A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension treatment 3 completed NCT06152861
Travoprost Ophthalmic Topical Cream for Open-angle Glaucoma or Ocular Hypertension treatment 2 recruiting NCT00047528
Phase 3 Study to Evaluate IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertension C-02-41 No drug interventions treatment 3 completed NCT04654611
Tafluprost Preservative Free Switch Study treatment 4 completed NCT00967811
A Study of Different Formulations of the L-PPDS in Subjects With OH or OAG No drug interventions treatment 2 completed NCT00047593
Phase 3 Study Comparing IOP Lowering in OAG or OH in Japanese Subjects C-01-98 No drug interventions treatment 3 completed NCT00347893
The Efficacy of Selective Laser Trabeculoplasty No drug interventions Not Available Not Available unknown_status NCT04024293
Intraocular Pressure Measured by a Novel Sensing Contact Lens Versus Tonometry No drug interventions diagnostic Not Available not_yet_recruiting NCT00834171
A Retrospective Evaluation of the Intraocular Pressure Spikes With Loteprednol and Loteprednol/Tobramycin Not Available Not Available completed NCT02730871
Safety and Efficacy of SIMBRINZA® BID as an Adjunctive to DUOTRAV® treatment 4 terminated NCT01062971
Clinical Study of A Fixed Combination of Timolol-Brimonidine-Dorzolamide treatment 2 completed NCT01369771
The Effects of Preservative-free Prostaglandin Eye Drops in Sign and Symptoms on the Eyes of Patients With Glaucoma treatment 4 completed NCT06177678
A Randomized, Open-label, Active-controlled, Phase 2a Clinical Trial to Evaluate the Efficacy and Safety of TFC-003 in Patients With Primary Open-angle Glaucoma or Ocular Hypertension treatment 2 not_yet_recruiting NCT01779778
Diurnal and Nocturnal Effect of Travatan With SofZia Preservative on Intraocular Pressure and Ocular Perfusion Pressure No drug interventions Not Available Not Available completed NCT01628588
Lumigan® in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT) Not Available Not Available completed NCT02108288
Pharmacokinetic Study of OPC-1085EL Ophthalmic Solution in Healthy Male Adult Volunteers Not Available 1 completed NCT01410188
Safety/Efficacy Study: OPA-6566 Ophthalmic Solution in Subjects With Primary Open-Angle Glaucoma or Ocular Hypertension treatment 1 / 2 completed NCT00675207
Comparison of Brimonidine Purite, Dorzolamide, and Brinzolamide as Adjunctive Therapy to Prostaglandin Analogs treatment 4 completed NCT01452009
Three Month Safety and Efficacy Study of TRAVATAN® Versus Travoprost Ophthalmic Solution, 0.004% treatment 3 withdrawn NCT00761709
Safety and Intraocular Pressure (IOP)-Lowering Efficacy of AL-39256 in Patients With Open-Angle Glaucoma or Ocular Hypertension treatment 2 completed NCT00430209
Neurovascular Coupling in Eyes of Glaucoma Patients No drug interventions Not Available Not Available completed NCT00620256
Adjunctive Study of AL-37807 Ophthalmic Suspension treatment 2 completed NCT01886456
IOP Lowering Effect of PLT Versus SLT in Naiv OAG Patients No drug interventions treatment Not Available unknown_status NCT01853085
A Study of Patients With Primary Open Angle Glaucoma or Ocular Hypertension Switched to Lumigan® UD Monotherapy for Medical Reasons Not Available Not Available completed NCT05273385
Efficacy of the Nanodropper Device on Intraocular Pressure in Patients With Glaucoma No drug interventions health_services_research Not Available recruiting NCT02105285
Efficacy and Safety Study of OPC-1085EL Ophthalmic Solution in Subjects With Glaucoma or Ocular Hypertension treatment 3 completed NCT02537015
An Open-label Extension Study to Evaluate the Safety of the 13 mg Bimatoprost Ocular Insert treatment 2 completed NCT01693315
Multiple Dose-escalation Study of AMA0076 in Patients With Ocular Hypertension or Primary Open-angle Glaucoma treatment 2 completed NCT00047515
Phase 3 Study to Evaluate IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertension C-01-69 No drug interventions treatment 3 completed NCT03067415
Exploratory Trial to Evaluate the Efficacy and Safety of D565H Twice Daily Versus D565 Once Daily treatment 2 unknown_status NCT01510132
Travacom Post Marketing Surveillance Study treatment 4 withdrawn NCT01987752
Safety and Efficacy of Combigan® Ophthalmic Solution in Korea Not Available Not Available completed NCT00781300
Intraocular Pressure With Loteprednol and Dexamethasone treatment 4 completed NCT01298700
Long-Term Safety of Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension treatment 4 completed NCT00293800
A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension treatment 3 completed NCT01978600
Evaluation of Intraocular Pressure Using Simbrinza™ in Patients With Open-Angle Glaucoma or Ocular Hypertension treatment 4 completed NCT00798759
Examination of Ocular Surface Effects With Administration of Travatan Z and XALATAN treatment 4 completed NCT02617459
Levobetaxolol Hydrochloride Eye Drops for Treatment of Primary Open-angle Glaucoma or Ocular Hypertension treatment 3 completed NCT00332059
Safety and Efficacy Study of Bimatoprost/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension treatment 3 completed NCT03419975
A Multi-center, Randomized, Blinded Evaluator, Active Control, Parallel, Phase III Study to Evaluate the Efficacy and Safety of TJO-002 in POAG or Ocular Hypertension Patients treatment 3 completed NCT02057575
Study Assessing Safety and Efficacy of PG324 Ophthalmic Solution in Patients With Elevated Intraocular Pressure treatment 2 completed NCT01594970
A Safety and Efficacy Study of Bimatoprost 0.01% in Primary Open-Angle Glaucoma (POAG) or Ocular Hypertension (OH) treatment 4 completed NCT01254370
Safety and Efficacy Study of Catioprost® (Unpreserved Latanoprost 0.005% Emulsion) Compared to Travatan Z® to Treat Glaucoma and Ocular Surface Disease treatment 2 completed NCT00716742
Safety and Efficacy Study of Bimatoprost, Latanoprost, and Travoprost in Patients With Elevated Intraocular Pressure (IOP) and Open-angle Glaucoma (OAG) Not Available Not Available completed NCT01864642
Effects of a Single OMT on Intraocular Pressure (IOP) in Ocular Hypertenive or Glaucoma Suspect Subjects No drug interventions treatment Not Available completed NCT00051142
A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Open-Angle Glaucoma (OAG) or Ocular Hypertension (OHT) treatment 3 completed NCT00061542
Safety and Efficacy Study of BETOPTIC S 0.25% and Timolol Gel-forming Solution 0.25% and 0.5% in Pediatric Patients With Glaucoma or Ocular Hypertension treatment 3 completed NCT00638742
A Phase 1, Open-Label Study of Latanoprost Acid Plasma Concentrations in Pediatric and Adult Glaucoma Patients Treated With Latanoprost. other 1 completed NCT02014142
A Phase 2 Single-Masked, Randomized Study of Latanoprost PPDS in Ocular Hypertension or Open-Angle Glaucoma treatment 2 completed NCT01217606
Safety and Efficacy of Triple Combination Therapy in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension treatment 3 completed NCT00047606
Phase 4 Study Comparing IOP Lowering in OAG or OH in Caucasian or Japanese Subjects C-02-32 No drug interventions treatment 4 terminated NCT00828906
DuoTrav® Eye Drops As Replacement Therapy Program treatment 4 completed NCT01927406
The Secondary Beneficial Effects of Prostaglandin Analog Treatment in Thyroid Eye Disease Patients. prevention 4 withdrawn NCT00140049
A 12week, Randomized, Evaluator-Masked, Parallel Group Comparing Evening Dosing Of Xalacom Vs Cosopt In Subj W/ Glaucoma treatment 4 completed NCT00735449
Comparing Efficacy and Safety of Combigan With Timolol Adjunctive to Xalatan in Glaucoma or Ocular Hypertension Subjects treatment 4 completed NCT02742649
A Study to Evaluate Efficacy and Safety of a Fixed Combination Ocular Insert in Participants With Open-angle Glaucoma or Ocular Hypertension treatment 1 / 2 completed NCT01789736
A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days treatment 2 completed NCT01979913
An Open, Non-randomized Pilot Study on the Effect of Preservative Free Tafluprost (Saflutan® Augentropfen) in Patients With Ocular Hypertension or Primary Open Angle Glaucoma With an Uncontrolled Intraocular Pressure of 30 mmHg and More treatment 4 completed NCT01265719
Long-Term Non-Interventional Latanoprost Study No drug interventions Not Available Not Available completed NCT05333419
Study of a Latanoprost Ocular Implant for Treatment of Open Angle Glaucoma or Ocular Hypertension. treatment 1 completed NCT00429819
Neurovascular Coupling in Eyes of Glaucoma Patients No drug interventions Not Available Not Available completed NCT01361841
Effects of Latanoprost, Bimatoprost and Travoprost in Patients With Latanoprost-resistant Glaucoma treatment Not Available unknown_status NCT01833741
A Study of LUMIGAN® RC in the Clinical Setting treatment 4 completed NCT00440141
Brimonidine 0.1% Versus Brinzolamide 1% as Adjunctive Therapy to Latanoprost 0.005% treatment 4 completed NCT00788541
A Dose-Volume Study of a Treatment for Elevated IOP Due to Open-Angle Glaucoma or Ocular Hypertension prevention 2 terminated NCT00047541
Phase 3 Study to Evaluate IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertension C-01-70 No drug interventions treatment 3 completed NCT01864317
Assessment of Optic Nerve Radiation in Patients With Glaucoma and Ocular Hypertension by 7 Tesla Diffusion Tensor Imaging No drug interventions basic_science 2 terminated NCT00108017
Comparison of the Effects of Two Glaucoma Drugs Over 24 Hours (0507A-137)(COMPLETED) treatment 3 completed NCT02801617
Non-inferiority of PRO-067 Ophthalmic Solution vs GAAP Ofteno® in Glaucoma or Ocular Hypertension treatment 3 terminated NCT02003534
A Study of 0.15% Brimonidine Tartrate in Patients With Primary Open Angle Glaucoma and Ocular Hypertension treatment 4 completed NCT00515424
Tolerability, Safety and Efficacy of RKI983 Eye Drops in Subjects With Primary Open Angle Glaucoma and Ocular Hypertension No drug interventions treatment 1 completed NCT04947124
A Study to Determine the Safety and Tolerability of 2 Concentrations of QLS-101 No drug interventions treatment 2 completed NCT01976624
Safety and Efficacy of Bimatoprost/Timolol (Ganfort®) Ophthalmic Solution in Korea Not Available Not Available completed NCT04524416
MINIject Global Long-Term Follow-up Study No drug interventions Not Available Not Available recruiting NCT05279716
Study in Prostaglandin Associated Peri-orbitopathy Switching From Prostaglandin Monotherapy to Omidenepag Isopropyl treatment 4 unknown_status NCT01520116
Study of the Safety and Efficacy of ATS907 in Subjects With Primary Open Angle Glaucoma (POAG) and Ocular Hypertension treatment 1 / 2 unknown_status NCT00652496
Safety and Efficacy Study of Different Formulations of Bimatoprost Once-Daily in Patients With Glaucoma or Ocular Hypertension treatment 2 completed NCT02295358
The Effect of Omega-3 Fatty Acid Supplementation on Intraocular Pressure & Ocular Surface No drug interventions Not Available Not Available withdrawn NCT03584958
Comparing Refractive and Visual Outcomes of MIGS and Traditional Surgeries No drug interventions Not Available Not Available unknown_status NCT00621335
A Investigator Masked Parallel Comparison of Tolerability of Combigan and Cosopt No drug interventions Not Available Not Available completed NCT03395535
Laser-1st vs Drops-1st for Glaucoma and Ocular Hypertension No drug interventions treatment 4 completed NCT00168363
Safety and Efficacy of Brimonidine in Patients With Glaucoma or Ocular Hypertension treatment 3 completed NCT00230763
Determination Of Predictive Factors Allowing To An Additional 10% Reduction Of Intra-Ocular Pressure treatment 3 completed NCT01215786
Safety and Pharmacodynamics Study of AGN-207281 Ophthalmic Solutions Compared With Timolol Ophthalmic Solution or Placebo in Patients With Ocular Hypertension or Primary Open-Angle Glaucoma treatment 1 completed NCT02030886
IOP Patterns in Ocular Hypertensive Patients Newly Converted to Glaucoma vs Stable Ocular Hypertensive Patients No drug interventions other Not Available terminated NCT05248139
Safety and Effectiveness of Drop-free Small Incision Cataract Surgery treatment Not Available unknown_status NCT01664039
An Efficacy and Tolerability Study of TRAVATAN® Versus LUMIGAN® treatment 4 completed NCT01033422
Safety and Efficacy of Daily CF101 Administered Orally in Subjects With Elevated Intraocular Pressure treatment 2 completed NCT00856622
A Study Demonstrating The Effect Of Latanoprost In Combination With Timolol, Latanoprost Alone And Timolol Alone On Eye Pressure In Open Angle Glaucoma Or Ocular Hypertension In Patients treatment 3 completed NCT05335122
A Study to Evaluate the Efficacy and Safety of OTX-TIC (Travoprost) Intracameral Implant for Patients With Open-angle Glaucoma (OAG) or Ocular Hypertension (OHT) treatment 2 active_not_recruiting NCT00941525
Central Corneal Thickness and 24-hour Fluctuation of Intraocular Pressure basic_science 4 completed NCT00333125
A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension treatment 3 completed NCT01749930
Comparing the Safety and Efficacy of BOL-303259-X Ophthalmic Solution With Timolol Maleate Ophthalmic Solution in Subjects With Open-Angle Glaucoma or Ocular Hypertension treatment 3 completed NCT00637130
Safety and Intraocular Pressure (IOP) Lowering Efficacy of Low Dose Travoprost treatment 2 completed NCT01999348
A Study of GANFORT® UD in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT) in a Medical Setting Not Available Not Available completed NCT04499248
AGN-193408 SR in the Treatment of Open-angle Glaucoma or Ocular Hypertension No drug interventions treatment 1 / 2 recruiting NCT00804648
Patient Satisfaction With Timolol in Subjects With Open-Angle Glaucoma or Ocular Hypertension treatment 4 completed NCT00809848
Safety and Efficacy of AGN 210669 Ophthalmic Solution in Patients With Ocular Hypertension or Primary Open-Angle Glaucoma treatment 1 / 2 completed NCT00539526
Evaluation of Hyperemia With the Use of Ocular Prostaglandin Analogues treatment 4 completed NCT03192826
Brinzolamide/Brimonidine Combination vs Brimonidine 0.2% in the Prevention of IOP Rise After Nd-YAG Laser Capsulotomy prevention 4 completed NCT01284166
Safety and Efficacy of Triple Combination Therapy With Dorzolamide Hydrochloride / Brimonidine Tartrate / Timolol Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension treatment 3 withdrawn NCT00744666
IntraVitreal Triamcinolone Acetonide: Preventing Raised Eye-pressure by Tracking Elevations After Topical Steroids screening 4 unknown_status NCT04863365
A Study of Efficacy and Safety of PHP-201 in Patients With Primary Open Angle Glaucoma or Ocular Hypertension treatment 3 unknown_status NCT04360174
CLN-0045: Safety, and Efficacy of OTX-TIC in Participants With Open Angle Glaucoma or Ocular Hypertension No drug interventions treatment 1 completed NCT04500574
Latanoprost Eluting Contact Lens for Treating Glaucoma and Ocular Hypertension treatment 1 recruiting NCT00824720
Safety and Efficacy of a Glaucoma Drug Delivery System No drug interventions treatment 2 completed NCT01281020
Adherence With Fixed Versus Unfixed Glaucoma Therapy No drug interventions Not Available Not Available completed NCT04401982
Measuring the Effects of Rhopressa on Episcleral and Retinal Blood Flow in Ocular Hypertension and Glaucoma Suspects Not Available Not Available completed NCT02165631
The Diurnal and Nocturnal Effect of Simbrinza and Timolol on Intraocular Pressure and Ocular Perfusion Pressure No drug interventions Not Available Not Available completed NCT05043831
Direct Selective Laser Trabeculoplasty in Ethnic Chinese Population The Zhuiguang Trial No drug interventions treatment Not Available withdrawn NCT01026831
Preservative-Free MK2452 (Tafluprost) for Open-Angle Glaucoma/Ocular Hypertension (MK2452-001)(COMPLETED) treatment 3 completed NCT00815373
The Effects of Cosopt® Vs Xalacom® on Ocular Hemodynamics and Intraocular Pressure (IOP) in Primary Open-angle Glaucoma (POAG) Not Available Not Available withdrawn NCT06394973
Efficacy and Safety Assessment of T4090 Ophthalmic Solution Versus Rhopressa® Ophthalmic Solution in Patients With Open-angle Glaucoma or Ocular Hypertension treatment 2 recruiting NCT01493427
Efficacy of Changing to TRAVATAN® From Prior Therapy treatment 4 completed NCT04595227
Glaucoma Screening Using Dynamic Analysis of Computerized Pupillary Light Reflex Assessment Device No drug interventions Not Available Not Available unknown_status NCT00751127
A 6 Month Study Comparing Latanoprost With Timolol in Patients With Open Angle Glaucoma or Ocular Hypertension treatment 3 completed NCT02348476
A Study of Simbrinza™ Therapy in Patients With Open-Angle Glaucoma or Ocular Hypertension No drug interventions Not Available Not Available completed NCT02140060
6-Week Proof-of-Concept Study of Travoprost/Brinzolamide Ophthalmic Suspension in Subjects With Open-Angle Glaucoma or Ocular Hypertension treatment 2 completed NCT02796560
Generic Travoprost Versus Brand Name Travoprost in Patients With Primary Open Angle Glaucoma or Ocular Hypertension treatment 4 completed NCT05159960
Optimal Treatment Protocol for Selective Laser Trabeculoplasty - Repeat Trial No drug interventions treatment Not Available enrolling_by_invitation NCT00767494
Travoprost/Brinzolamide Fixed Combination Versus Travatan and Versus AZOPT treatment 3 terminated NCT00690794
Travatan Z in Ocular Surface Health in Patients With Open-Angle Glaucoma or Ocular Hypertension treatment 3 completed NCT00051194
A 6-week Safety & Efficacy Study of Combination Intraocular Pressure-lowering Therapy in Patients With Open-angle Glaucoma or Ocular Hypertension No drug interventions treatment 2 completed NCT03529591
Is the Reduction in IOP After Treatment of 180 Degrees Equivalent to Treatment of 360 Degrees With SLT? No drug interventions treatment Not Available completed NCT02003391
Efficacy of Travoprost/Timolol for Uncontrolled Intraocular Pressure treatment 4 completed NCT02207491
Double-masked Study of AR-13324 Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension treatment 3 completed NCT01016691
Safety and Efficacy of a Drug Delivery System in Glaucoma treatment 2 completed NCT01227291
SYL040012. Tolerance and Effect on Intraocular Pressure in Subjects With Intraocular Pressure (IOP) >= 21 mm Hg treatment 1 / 2 completed NCT00596791
Ocular Signs and Symptoms in Glaucoma Patients Switched From Latanoprost 0.005% to Preservative Free Tafluprost Eye Drops treatment 3 completed NCT01781962
A Study of Quantitative Assessments of Angle Width in Chinese Patients With Open-angle Glaucoma and/or Ocular Hypertension No drug interventions Not Available Not Available terminated NCT01229462
Safety and Efficacy of Brimonidine Tartrate/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension treatment Not Available completed NCT00892762
Travoprost APS Versus Xalatan® in Patient Reported Outcomes and Ocular Surface Health treatment 3 completed NCT02743780
A Three Part Study of MGV354 in Ocular Hypertension or Glaucoma No drug interventions other 1 / 2 completed NCT03825380
Efficacy and Safety Assessment of T4032 Versus Lumigan® in Ocular Hypertensive or Glaucomatous Patients treatment 3 completed NCT00471380
A Phase IV Study of Travoprost + Brinzolamide to Treat Glaucoma or Ocular Hypertension treatment 4 completed NCT04285580
A Phase 3b Study Evaluating the 24-Hour Intraocular Pressure Lowering Effect of Bimatoprost SR in Patients With Open-Angle Glaucoma or Ocular Hypertension treatment 3 completed NCT00061529
A Phase III Study of Brimonidine Tartrate Ophthalmic Solution, 0.15% in Patients With Open-Angle Glaucoma or Ocular Hypertension treatment 3 completed NCT01936389
A Prospective Study to Assess the Hypotensive Efficacy of Rho-Kinase Inhibitor AR-12286 Ophthalmic Solution 0.5% and 0.7% in Patients With Exfoliation Syndrome and Ocular Hypertension or Glaucoma No drug interventions treatment 2 completed NCT00311389
A 12-Month Study to Evaluate the Efficacy and Safety of Once-Daily Instillation of Combination Glaucoma Therapy in Patients With Open-Angle Glaucoma or Ocular Hypertension treatment 3 completed NCT00934089
A Phase 2 Study Of The 24-Hour Intraocular Pressure Lowering And Systemic Exposure Of PF-04217329 treatment 2 completed NCT04702789
Comparative Study of the Efficacy of Either Krytantek Ofteno PF® or Eliptic Ofteno PF® Plus Gaap Ofteno PF® for POAG or Ocular Hypertension. treatment 4 terminated NCT00527592
A Single Dose Comfort Comparison of Travatan Z in One Eye Versus Xalatan in the Opposite Eye in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension treatment 4 completed NCT02312544
Phase 2b Study Evaluating Safety and Efficacy of OTX-TP Compared to Timolol Drops in the Treatment of Subjects With Open Angle Glaucoma or Ocular Hypertension treatment 2 completed NCT01739244
Dose Finding Clinical Trial With SYL040012 to Evaluate the Tolerability and Effect on Intraocular Pressure in Subjects With Ocular Hypertension or Open Angle Glaucoma treatment 2 completed NCT02136940
Multiple Dose-parallel-group Study of AMA0076 in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension treatment 2 completed NCT01467440
Efficacy of Selective Laser Trabeculoplasty in Patients Under Treatment With Topical Prostaglandines No drug interventions Not Available Not Available unknown_status NCT01830140
A Safety Study of Bimatoprost in Patients With Glaucoma or Ocular Hypertension treatment 3 completed NCT00656240
To Investigate the Safety and Efficacy of DE-104 Ophthalmic Solution to Treat Open-Angle Glaucoma or Ocular Hypertension No drug interventions Not Available 2 completed NCT00332540
Safety and Efficacy Study of Bimatoprost/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension treatment 3 completed NCT00800267
A Study of Glaucoma or Ocular Hypertension in Patients Within the United States treatment 3 completed NCT00150267
A 5-Year Postmarketing Safety Study Of Xalcom In Patients With Open Angle Glaucoma Or Ocular Hypertension treatment 3 completed NCT01426867
A Comfort Study of Brinzolamide 1% / Brimonidine 0.2% Fixed Combination, Brinzolamide 1% and Brimonidine 0.2% treatment 2 completed NCT00595101
A Phase 2, Dose Finding Study of PF-03187207 in Patients With Primary Open Angle Glaucoma or Ocular Hypertension. treatment 2 completed NCT00683501
Safety, Efficacy, and Pharmacokinetic Profile of DNB-001 in Subjects With Elevated Intraocular Pressure treatment 1 / 2 completed NCT00527501
IOP Lowering Efficacy of Travoprost/Brinzolamide Fixed Combination Ophthalmic Suspension in Patients With Open-Angle Glaucoma or Ocular Hypertension treatment 2 completed NCT01628601
GANfort® in Patients With Primary Open Angle Glaucoma or Ocular Hypertension Who Are Insufficiently Responsive to Monotherapy Not Available Not Available completed NCT02247804
Efficacy and Safety Study of Bimatoprost Sustained-Release (SR) in Participants With Open-angle Glaucoma or Ocular Hypertension treatment 3 completed NCT01309204
Brinzolamide/Brimonidine Twice a Day (BID) Fixed Combination (FC) vs Brinzolamide BID Plus Brimonidine BID in Patients With Open Angle Glaucoma or Ocular Hypertension treatment 3 completed NCT02384772
Survey of Patients Taking IOP-Lowering Eye Drops No drug interventions Not Available Not Available completed NCT00862472
Safety and Efficacy Study of DuoTrav APS Versus DuoTrav treatment 3 withdrawn NCT02105272
Efficacy and Safety Study of OPC-1085EL Ophthalmic Solution in Subjects With Glaucoma or Ocular Hypertension treatment 3 completed NCT04024072
To Compare the Safety and Efficacy of Perrigo's Product to an FDA Approved Product for the Treatment of Glaucoma or Ocular Hypertension in Both Eyes treatment 3 completed NCT00471068
Study of Travatan and Cosopt in Primary Open-Angle Glaucoma or Ocular Hypertension treatment 4 terminated NCT05495269
Safety and Tolerability Study of QLS-101 in Adolescents With Sturge-Weber Syndrome (SWS)-Related Glaucoma Due to Elevated Episcleral Venous Pressure (EVP) No drug interventions treatment 2 completed NCT03318146
Safety, Tolerability and Preliminary Efficacy of Unilateral Latanoprost-loaded Punctual Plug -EXP-LP treatment Not Available unknown_status NCT05181046
Evaluation of Nanodropper-mediated Microdrops vs. Standard Drops of 0.5% Timolol Maleate in Glaucoma Patients No drug interventions treatment Not Available completed NCT02874846
Nocturnal/Diurnal Intraocular Pressure-Lowering Effect of Netarsudil Ophthalmic Solution treatment 2 completed NCT03891446
Long-term Safety and Efficacy Extension Trial of Bimatoprost SR treatment 3 enrolling_by_invitation NCT02571712
Safety of GANFORT® Ophthalmic Solution in Chinese Patients With Open-angle Glaucoma or Ocular Hypertension treatment 4 completed NCT00651612
Study to Evaluate Safety of Brimonidine/Timolol Fixed Combination in Glaucoma or Ocular Hypertension Patients treatment 3 completed NCT01937312
Effect of SIMBRINZA® Suspension as an Added Therapy to a Prostaglandin Analogue treatment 4 completed NCT00051181
A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Chronic Angle-Closure Glaucoma treatment 3 completed NCT01707381
BOL-303259-X With Timolol 0.5% in Subjects With Open-Angle Glaucoma or Ocular Hypertension treatment 2 completed NCT00761995
Safety and Efficacy of Brinzolamide Dosed TID With Dorzolamide Dosed TID in Reducing Intraocular Pressure in Patients With Open Angle Glaucoma or Ocular Hypertension treatment 4 completed NCT04972695
Validation of an Automatic Analysis Algorithm of the Probability of Glaucoma From Optic Disc Images No drug interventions Not Available Not Available completed NCT01001195
Safety and Efficacy of Three Formulations of AGN-210669 Ophthalmic Solution Compared With Bimatoprost Ophthalmic Solution treatment 2 completed NCT01168414
A Study of Ganfort Versus Duotrav in Patients With Primary Open Angle Glaucoma or Ocular Hypertension treatment 3 completed NCT04647214
18 Month Prospective Efficacy and Safety Study of Bimatoprost Intracameral Implant (DURYSTA) No drug interventions Not Available Not Available completed NCT01975714
Intraocular Pressure and Tolerability Study of Preservative-free Prostaglandins (Bimatoprost and Latanoprost) on Glaucoma and Ocular Hypertension: European, Multicentric, Investigator-led, Single Masked Study treatment 4 completed NCT02967614
KJ-TFC-004 Drug-drug Interaction Study treatment 1 completed NCT00572455
Safety and Efficacy of PF-04217329 in Patients With Glaucoma or Elevated Eye Pressure. treatment 2 completed NCT00822055
Comparison of the Fixed Combinations of Brimonidine/Timolol and Dorzolamide/Timolol in Subjects With Open-Angle Glaucoma or Ocular Hypertension treatment 4 completed NCT01453855
Travoprost 3-Month Safety and Efficacy Study treatment 3 completed NCT00051155
A 6-Week Safety and Efficacy Study of Travatan Compared to Xalcom in Subjects With Open-Angle Glaucoma(OAG) or Ocular Hypertension(OHT) treatment 3 completed NCT02434250
Selective Laser Trabeculoplasty After Failed Phacoemulsification With Eximer Laser Trabeculectomy No drug interventions treatment Not Available completed NCT02102750
A Study to Evaluate Pharmacokinetics of Tafluprost Ophthalmic Solution (0.0015%) in Pediatric Patients With Glaucoma or Ocular Hypertension treatment 1 completed NCT01632423
A Study of Lumigan® in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT) Not Available Not Available completed NCT04448223
A Clinical Study to Evaluate the Efficacy and Safety of CKD-351 treatment 2 unknown_status NCT02628223
180 Degree vs. 360 Degree Selective Laser Trabeculoplasty as Initial Therapy for Glaucoma No drug interventions treatment Not Available completed NCT02623023
Prophylaxis for Anti-VEGF-induced IOP Elevation prevention Not Available withdrawn NCT02419508
SIMBRINZA® Suspension BID as an Adjunctive to Prostaglandin Analogue (PGA) treatment 4 completed NCT01291108
Safety and Efficacy of AGN-210669 Ophthalmic Solution Compared With Bimatoprost Ophthalmic Solution in Patients With Open-Angle Glaucoma or Ocular Hypertension treatment 2 completed NCT02379208
Evaluation of Rate of Progression With Perimetry in Newly Diagnosed Open Angle Glaucoma No drug interventions Not Available Not Available unknown_status NCT01568008
Observational Study of Lumigan® 0.01% for Treatment of Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT) Not Available Not Available completed NCT01191008
Long Term Use Of Xalacom In Patients Glaucoma Or Ocular Hypertension Not Available Not Available completed NCT00650338
Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension treatment 2 completed NCT00476138
Effect of Epigallocatechin-Gallate on Inner Retinal Function in Ocular Hypertension and Early Glaucoma supportive_care 1 / 2 unknown_status NCT00823043
A Comfort Survey of Open-angle Glaucoma or Ocular Hypertension Patients Treated With 2 Drugs Not Available Not Available completed NCT06441643
Next Generation Rocklatan treatment 2 not_yet_recruiting NCT01216943
Safety and Efficacy of Triple Combination Therapy in Patients With Glaucoma or Ocular Hypertension treatment 3 completed NCT00061503
Mechanism of Action of TRAVATAN 0.004% in Subjects With Glaucoma or Ocular Hypertension treatment 4 completed NCT02839590
Aqueous Dynamics and Glaucoma Surgeries No drug interventions Not Available Not Available unknown_status NCT01111890
Comparison of the Efficacy of AZARGA® Versus COSOPT® in Patients With Open-Angled Glaucoma or Ocular Hypertension treatment 4 completed NCT04442464
Intraocular Pressure in Ocular Hypertensives With Scleral Lens Wear No drug interventions other Not Available terminated NCT00811564
An Evaluation of the Fixed Combination Brimonidine Tartrate 0.2%/ Timolol Maleate 0.5% to Latanoprost 0.005% in Glaucoma or Ocular Hypertension Subjects treatment 4 completed NCT02246764
Study of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension treatment 3 completed NCT01157364
Safety and Efficacy of a New Ophthalmic Formulation of Bimatoprost in Patients With Open Angle Glaucoma and Ocular Hypertension treatment 1 / 2 completed NCT01028664
Use of an Ocular Telemetry Sensor in Diamox Treated Patients No drug interventions supportive_care Not Available completed NCT00545064
Dry Eye Study With Cosopt® Over 8 Weeks in Patients With Open-Angle Glaucoma or Ocular Hypertension (0507A-152)(COMPLETED) treatment 4 completed NCT01068964
Safety and Efficacy of Bimatoprost Timolol Ophthalmic Solution in Patients With Open Angle Glaucoma or Ocular Hypertension treatment Not Available completed NCT02207621
Evaluation of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Glaucoma and Ocular Hypertension treatment 3 completed NCT00287521
A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension treatment 2 completed NCT00650702
Safety and Efficacy of Punctum Plug Delivery System in Subjects With Open-Angle Glaucoma or Ocular Hypertension treatment 2 completed NCT01731002
Study Comparing the Safety and Efficacy of AR-13324 to Latanoprost in Patients With Elevated Intraocular Pressure treatment 2 completed NCT01253902
Ocular Surface Tolerability Study of Prostaglandin Analogues in Patients With Open-Angle Glaucoma or Ocular Hypertension treatment 4 completed NCT01084902
Efficacy Comparison of Xalatan and Azopt on POAG and OH treatment Not Available unknown_status NCT01170884
Comparing Safety and Efficacy of Combigan® and Lumigan® With Lumigan® Alone in Glaucoma or Ocular Hypertension Subjects Treated With Xalatan® treatment 4 completed NCT00332384
Safety and Efficacy Study of Brimonidine/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension treatment 3 completed NCT04140279
A Study to Evaluate the Effect of Latanoprostene Bunod Ophthalmic Solution 0.024% on Episcleral Venous Pressure and Outflow Facility in Participants With Ocular Hypertension treatment 4 withdrawn NCT01298687
Divided Dose of TRAVATAN® treatment 2 completed NCT00803387
Dry Eye and Irritation Comparison of Latanoprost With the Preservative Versus Travoprost Without Preservative Not Available Not Available completed NCT03204487
A Study on the Effect of Changing From Preserved Prostaglandin Formulations to Preservative Free Tafluprost on Tear Film Thickness treatment 4 completed NCT04911387
iCare® Home vs Goldmann Applanation Tonometry No drug interventions Not Available Not Available completed NCT00670033
Travoprost New Formulations in Patients With Open-Angle Glaucoma or Ocular Hypertension treatment 2 completed NCT02674854
Double-masked Study of PG324 Ophthalmic Solution in Patients With Open-angle Glaucoma or Ocular Hypertension treatment 3 completed NCT03201354
Efficacy and Safety of the ExPRESS Implant Versus Deep Sclerectomy in Combined Surgery No drug interventions treatment Not Available completed NCT02250651
Efficacy and Safety of Bimatoprost Sustained-Release (SR) in Patients With Open-Angle Glaucoma or Ocular Hypertension treatment 3 completed NCT00872651
Travoprost 0.004%/Timolol 0.5% Versus Latanoprost 0.005%/Timolol in Chinese Patients With Open-Angle Glaucoma or Ocular Hypertension treatment 3 completed NCT01863953
A Safety and Efficacy Study of Fixed-Combination Bimatoprost and Brimonidine in Chronic Glaucoma or Ocular Hypertension treatment 2 completed NCT03284853
Safety and Efficacy Study of PG324 (Netarsudil/Latanoprost 0.02% / 0.005%) Ophthalmic Solution Compared to GANFORT® Ophthalmic Solution in Open Angle Glaucoma or Ocular Hypertension treatment 3 completed NCT01310777
Brinzolamide/Brimonidine Twice a Day (BID) Fixed Combination (FC) vs Brinzolamide BID and Brimonidine BID in Patients With Open Angle Glaucoma or Ocular Hypertension treatment 3 completed NCT00121147
Additivity Study: Additive Effect on Eye Pressure of Azopt and Alphagan P to Travatan treatment Not Available completed NCT01012245
Non-Interventional Study In Patients With Ocular Hypertension And Open Angle Glaucoma Treated With Xalatan And Xalacom No drug interventions Not Available Not Available completed NCT03844945
Efficacy and Systemic Safety of Netarsudil 0.01%, 0.02%, 0.04% Relative to Placebo in Subjects With Open-angle Glaucoma or Ocular Hypertension in Japan treatment 2 completed NCT02993445
Effect of Alternate Therapies on Intraocular Pressure in Ocular Hypertension No drug interventions treatment Not Available completed NCT04405245
Study to Assess the Efficacy, Safety and Tolerability of AKB-9778 Ophthalmic Solution as and Adjunct to Latanoprost in Patients With Ocular Hypertension or Open Angle Glaucoma treatment 2 completed NCT00332345
Safety and Efficacy Study of Brimonidine/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension treatment 2 completed NCT01177098
Safety and Efficacy of a New Formulation of Bimatoprost/Timolol Ophthalmic Solution Compared With Bimatoprost/Timolol Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension treatment 3 completed NCT01547598
Safety and Efficacy of LUMIGAN® RC Versus DuoTrav® in Patients Who Require Further Intraocular Pressure (IOP) Reduction treatment 4 completed NCT00277498
A 12-week, Randomized, Double-masked, Parallel Group Comparison of Evening Dosing With Xalacom in Subjects With Glaucoma treatment 3 completed NCT00672997
A Phase III Study of Travoprost/Timolol Combination in Patients With Open-Angle Glaucoma or Ocular Hypertension treatment 3 completed NCT06572397
Open-Label Study of Safety of H1337 in Healthy Volunteers No drug interventions treatment 1 not_yet_recruiting NCT04830397
Study to Evaluate QLS-101 Compared to Timolol Maleate Eye Drops in Subjects With High Eye Pressure (Glaucoma or Ocular Hypertension). treatment 2 completed NCT01696383
Assessing the Efficacy of DuoTrav as a Replacement Therapy in Glaucoma Patients in Russia treatment 4 withdrawn NCT00847483
Comparison of Latanoprost With Travoprost and Bimatoprost in Patients With Elevated IOP. A 12-weeks, Masked Evaluator, Phase IV Multi-center Study in the US treatment 4 completed NCT00441883
Dose-Finding Study Comparing the Safety and Efficacy of Latanoprost to a Novel Treatment for Glaucoma treatment 2 completed NCT06455683
The A D A G I O Study No drug interventions Not Available Not Available not_yet_recruiting NCT02061683
A Study of Bimatoprost in the Treatment of Primary Open Angle Glaucoma and Ocular Hypertension treatment 4 completed NCT01814761
A Study of Bimatoprost 0.01% in the Clinical Setting Not Available Not Available completed NCT01306461
Tafluprost-Timolol Fixed Dose Combination Non-Inferiority Study Against Concomitant Administrations treatment 3 completed NCT00947661
Efficacy and Safety of SPARC0912 and Reference0912 in Open Angle Glaucoma or Ocular Hypertension No drug interventions treatment 3 completed NCT00001161
Abnormalities of the Eye's Anterior Chamber, Iris, Cornea and Lens No drug interventions Not Available Not Available completed NCT01528111
Study to Evaluate the Safety, Tolerability, and Efficacy of LX7101 in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension treatment 1 / 2 completed NCT00567411
Comparison of the Alpha-2 Agonists for Prevention of Intraocular Pressure Elevation After Selective Laser Trabeculoplasty treatment Not Available unknown_status NCT00440011
Bimatoprost 0.03% Versus Travoprost 0.004% in Patients Currently on Latanoprost 0.005% treatment 4 completed NCT00402493
Study to Determine if Taking OTC Non-Steroidal Anti-Inflammatory Affects Eye Pressure in Patients Using Glaucoma Drops treatment Not Available completed NCT01114893
Travoprost Five Day Posology Study treatment 2 completed NCT05299593
24-hour Efficacy and Tolerability of the Tafluprost-timolol Fixed Association Without Preservatives in Glaucomatous or Ocular Hypertensive Patients Already Treated With Latanoprost Preserved With BAK. A Prospective, Open Study of 3 Months Duration. supportive_care 4 unknown_status NCT01087671
Ocular Signs and Symptoms in Glaucoma Patients Switched From Latanoprost to Preservative Free Tafluprost Eye Drops treatment 3 completed NCT01261871
Intraocular Pressure During Robotic Assisted Laparoscopic Procedures Utilizing Steep Trendelenburg Positioning No drug interventions Not Available Not Available completed NCT00314171
A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension treatment 3 completed NCT02059278
Safety and Efficacy of T-2345 Compared to Xalatan in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension treatment 3 completed NCT04891588
Switching From the Preserved to the Preservative - Free Latanoprost - Timolol FC in Glaucoma Patients With OSD treatment Not Available unknown_status NCT01446588
Ocular Hypertension And Yoga Study No drug interventions treatment Not Available withdrawn NCT03808688
Study of Rhopressa® for the Reduction of Elevated Intraocular Pressure in Patients With Glaucoma or Ocular Hypertension in a Real-world Setting treatment 4 completed NCT01467388
Efficacy of Selective Laser Trabeculoplasty in Pseudophakic Patients No drug interventions Not Available Not Available unknown_status NCT01721707
Latanoprost/Brinzolamide BID Versus Latanoprost BID in Patients With OAG or OH treatment 3 withdrawn NCT02989909
Clinical Evaluation of CATS Tonometer Prism No drug interventions diagnostic Not Available completed NCT01719809
An Evaluation of the Ability to Train Established Glaucoma Patients Who Have Difficulty in Drop Instillation No drug interventions Not Available Not Available terminated NCT02914509
Phase 3 Study Evaluating Safety and Efficacy of OTX-TP in Subjects With OAG or OHT treatment 3 completed NCT01123785
A Dose-Escalation Study Designed to Evaluate the Tolerability, Safety, Pharmacokinetics (PK), and Efficacy of Chronic Topical Ocular Application of INO-8875 in Adults With Ocular Hypertension or Primary Open-Angle Glaucoma treatment 1 / 2 completed NCT00304785
Latanoprost Versus Fotil treatment 4 completed NCT00804115
The International Collaborative Exfoliation Syndrome Treatment Study treatment Not Available unknown_status NCT00676637
Glaucoma Adherence Study Not Available Not Available completed NCT06582732
Performance of the Travoprost Intraocular Implant treatment 2 completed NCT03235232
BREMEN Eye Drops Versus Combigan for Open-angle Glaucoma or Intraocular Hypertension treatment 3 completed NCT05913232
Study of Safety and Efficacy of H-1337 in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension treatment 2 active_not_recruiting NCT00486252
Non Interventional Study in Patients With Open Angle Glaucoma and/or Ocular Hypertension Treated With XALATAN® No drug interventions Not Available Not Available completed NCT00001152
Pigment Dispersion Syndrome With and Without Glaucoma No drug interventions Not Available Not Available completed NCT04585100
FM101 Safety, Tolerability, Efficacy Study in the Patients With Ocular Hypertension No drug interventions treatment 1 / 2 unknown_status NCT05397600
Efficacy and Safety Assessment of T4032 (Unpreserved Bimatoprost 0.01%) Versus Lumigan® 0.01% in Ocular Hypertensive or Glaucomatous Patients treatment 3 completed NCT02558400
Double-masked Study of PG324 Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension treatment 3 completed NCT00820300
A Safety Study of the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open Angle Glaucoma treatment 2 completed NCT04910100
Nebivolol 0.5, 1.0, or Timolol 0.5 Suspension Compared to Timolol 0.5 Solution to Treat Glaucoma/Ocular Hypertension treatment 2 completed NCT00651859
Safety and Efficacy Study of Bimatoprost in Ethnically Japanese Patients With Open-Angle Glaucoma or Ocular Hypertension treatment 2 completed NCT02585375
Latanoprost Preserved Versus Unpreserved: Effect on Tear Film Thickness as Measured With OCT basic_science 4 unknown_status NCT03926975
The Effect of a Scleral Lens on the Anterior Chamber Depth and Minimum Rim Width No drug interventions basic_science Not Available completed NCT01540370
Study Comparing Quantitative Assessments in Open-angle Glaucoma (OAG) and/or Ocular Hypertension (OHT) No drug interventions Not Available Not Available completed NCT05277870
Use of Nanodropper vs. Standard Eyedropper in Patients With Glaucoma and Ocular Hypertension No drug interventions supportive_care Not Available recruiting NCT01489670
Observational Study of Lumigan® 0.01% Treatment for Patients With Primary Open Angle Glaucoma or Ocular Hypertension Not Available Not Available completed NCT00541242
Safety and Efficacy of Bimatoprost Compared With Latanoprost in Patients With Glaucoma or Ocular Hypertension treatment 4 completed NCT00576342
Patient Preference Study treatment 3 completed NCT06120842
Evaluation of the Bimatoprost Implant System Used in Combination With the SpyGlass Intraocular Lens Compared to Timolol Ophthalmic Solution treatment 1 / 2 recruiting NCT00273442
Assessing Cosopt Switch Patients treatment 4 completed NCT01937299
Effect of SIMBRINZA® Suspension as an Added Therapy to TRAVATAN Z® treatment 4 completed NCT00845299
Study of the Effects of Artificial Tears on the Response to the Latanoprost Punctal Plug Delivery System in Subjects With Ocular Hypertension or Open-Angle Glaucoma treatment 2 completed NCT01327599
Efficacy of Changing to DUOTRAV® From Prior Therapy treatment 4 completed NCT01110499
Safety and Efficacy of AGN-210961 Ophthalmic Solution Compared With Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension treatment 2 completed NCT04149899
Safety and IOP-Lowering Effects of WB007 treatment 1 / 2 completed NCT00069706
Phase II Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-angle Glaucoma or Ocular Hypertension Patients treatment 2 completed NCT00652106
Safety and Efficacy Study of Brimonidine/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension treatment 3 completed NCT01302249
AR-12286 in Combination With Latanoprost treatment 2 completed NCT00961649
Safety and Efficacy of Brinzolamide/Brimonidine Fixed Combination treatment 2 terminated NCT00751049
A Study of Open Angle Glaucoma or Ocular Hypertension in Patients Within the United Kingdom treatment 3 completed NCT01037036
A Study of the L-PPDS With Adjunctive Xalatan® Eye Drops in Subjects With OH or OAG treatment 2 completed NCT00332436
Safety and Efficacy Study of Brimonidine/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension treatment 3 completed NCT00848536
Efficacy Study of Travoprost APS Versus TRAVATAN treatment 3 completed NCT01995136
Investigation of Intraocular Pressure (IOP) Reduction Efficacy of Travoprost Ophthalmic Solution in Patients With Normal Tension Glaucoma treatment 4 completed NCT03257813
Non-inferiority of PRO-122 Ophthalmic Solution vs KRYTANTEK Ofteno® in Glaucoma or Ocular Hypertension (CONFORTK) treatment 3 completed NCT02394613
A Phase I Clinical Trial of DARC No drug interventions diagnostic 1 unknown_status NCT06144918
Phase 2, Placebo-Controlled, Study Assessing the Safety and Ocular Efficacy of SBI-100 Ophthalmic Emulsion in Patients With Elevated Eye Pressure treatment 2 completed NCT02325518
Comparison of Intraocular Pressure (IOP)-Lowering Efficacy and Safety of AZORGA® Ophthalmic Suspension and COSOPT® Ophthalmic Solution Not Available 4 completed NCT06061718
Travoprost Intraocular Implant in Conjunction With Cataract Surgery treatment 3 active_not_recruiting NCT00069719
Phase II Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-Angle Glaucoma or Ocular Hypertension Patients No drug interventions treatment 2 completed NCT04445519
Phase 3 Trial of NCX 470 vs. Latanoprost in Subjects With Open-Angle Glaucoma or Ocular Hypertension treatment 3 completed NCT00383019
A Study Comparing Xalacom And Xalatan In Patients With Primary Open Angle Glaucoma (POAG) Or Ocular Hypertension (OH). treatment 3 completed NCT00761319
Phase III Clinical Trial of TRAVATAN Z in Ocular Surface Health treatment 3 completed NCT02097719
Efficacy and Safety Study of Bimatoprost 0.01% Alone Compared With Travoprost 0.004% and Timolol 0.5% in Subjects With Glaucoma or Ocular Hypertension treatment 4 completed NCT00855517
A Phase 2 Study of the Latanoprost Punctal Plug Delivery System in Subjects With Ocular Hypertension or Open-Angle Glaucoma treatment 2 withdrawn NCT00878917
Equivalence Study of Dorzolamide 2% Eye Drops Solution treatment 3 completed NCT01297517
Efficacy and Safety Study of Brinzolamide 1%/Brimonidine 0.2% vs. Brinzolamide 1% and Brimonidine 0.2% treatment 3 completed NCT02891317
Assessing Ocular Hemodynamic Response to Surgical Intervention in Glaucoma No drug interventions Not Available Not Available terminated NCT01464424
Assessment of Intraocular Pressure (IOP) Control in Subjects With Open-Angle Glaucoma or Ocular Hypertension Treated With Travoprost 0.004% (TRAVATAN® Z) or Bimatoprost 0.01% (LUMIGAN®) treatment 4 completed NCT03868124
Clinical Study Comparing Two Models of a Travoprost Intraocular Implant treatment 3 active_not_recruiting NCT05456724
A Study to Investigate the Effect of IOP-lowering With TO-O-1001 Eye Drops in Healthy Subjects and in Patients With Open-Angle Glaucoma or Ocular Hypertension No drug interventions treatment 1 / 2 active_not_recruiting NCT02863224
Advanced Glycation End Products as a Biomarker for Accelerated Ageing No drug interventions Not Available Not Available completed NCT01668524
ATS907 Ph2a Open-Label Dose-ranging Safety and Tolerability in Primary Open Angle Glaucoma (POAG) and Ocular Hypertension (OHT) Subjects No drug interventions treatment 2 completed NCT00443924
Study of INS115644 Ophthalmic Solution in Subjects With Ocular Hypertension or Glaucoma No drug interventions treatment 1 completed NCT00061516
Safety and Efficacy Study of BETAXON 0.5% and AZOPT 1.0% in Pediatric Patients With Glaucoma or Ocular Hypertension treatment 3 completed NCT02710916
SD-OCT Multimodal Analysis in GLaucoma No drug interventions diagnostic Not Available completed NCT01357616
Fixed Combination Brinzolamide 1%/Timolol 0.5% Versus Brinzolamide 1% + Timolol 0.5% in Open-Angle Glaucoma or Ocular Hypertension treatment 3 completed NCT00219596
Xalacom And Combination Of Unfixed Latanoprost And Timolol In Subjects With Open-Angle Glaucoma Or Ocular Hypertension treatment 3 completed NCT00825396
An Open-Label Study of an Ophthalmic Solution to Reduce Intraocular Pressure in Patients With Ocular Hypertension No drug interventions treatment Not Available completed NCT00424996
Utility of Heidelberg Retina Tomograph in Monitoring Glaucoma Progression No drug interventions Not Available Not Available completed NCT00941096
Intraocular Pressure Reduction With the Bimatoprost/Timolol Fixed Combination treatment 4 completed NCT01655758
24-hour Control of Intraocular Pressure (IOP) in Ocular Hypertension treatment 4 completed NCT00945958
Evaluation of Safety of SPARC0913 in Open Angle Glaucoma or Ocular Hypertension No drug interventions treatment 3 completed NCT00314158
A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension treatment 3 completed NCT01474135
AR-12286 Fixed Dose Combination to Lower Elevated Intraocular Pressure treatment 2 completed NCT04620135
Efficacy and Safety Study of Netarsudil 0.02% Ophthalmic Solution Compared to Ripasudil Hydrochloride Hydrate 0.4% Ophthalmic Solution in Japanese Subjects With Primary Open Angle Glaucoma or Ocular Hypertension treatment 3 completed NCT02167035
Comparison of Combigan Two Times Daily (BID) Versus Simbrinza Three Times Daily (TID) treatment 4 completed NCT01210963
Central Corneal Thickness With SENSIMED Triggerfish No drug interventions Not Available Not Available completed NCT03519386
Randomized Study Comparing Two Models of a Travoprost Intraocular Implant to Timolol Maleate Ophthalmic Solution, 0.5% treatment 3 active_not_recruiting NCT00546286
A Study to Evaluate the Effectiveness of Cosopt® as First Line Therapy (MK-0507A-153) treatment 3 completed NCT01271686
24-hour IOP-lowering Effect of 0.01% Bimatoprost treatment 4 completed NCT00759239
Phase IV Randomised Double-masked Clinical Trial: Assessing Morning Versus Evening Dosing of a Fixed Dose Combination of Travoprost 0.004% / Timolol Maleate 0.5% in Patients With Primary Open-angle Glaucoma or Ocular Hypertension treatment 4 completed NCT01658839
Pharmacokinetic and Safety Study of Travoprost 0.004% in Pediatric Glaucoma Patients treatment 1 completed NCT04035239
Retinal Effects of Balance Goggles System in Glaucoma Balance Goggles System (BGS) in Patients With Glaucoma No drug interventions treatment 1 completed NCT00760539
Safety and Efficacy of Travoprost/Timolol BAC-free treatment 3 completed NCT04743622
Comparison of Efficacy and Ocular Surface Disease Assessment Between Monoprost and BAK-preserved Latanoprost treatment 4 completed NCT00708422
Effects of Travatan Z and Xalatan on Ocular Surface Health treatment 4 completed NCT04335825
Surgical and Refractive Outcomes of Combined Glaucoma Surgery No drug interventions treatment Not Available completed NCT00000125
Ocular Hypertension Treatment Study (OHTS) No drug interventions prevention 3 completed NCT02047630
Efficacy of the Brand-name Latanoprost and One of Its Generic Version in Primary Open Angle Glaucoma and Ocular Hypertension treatment 4 terminated NCT03870230
Investigation of Neurovascular Coupling in Glaucoma Patients and Healthy Subjects No drug interventions basic_science Not Available unknown_status NCT05401357
Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% and LUMIGAN® in the Treatment of Chronic Open-Angle Glaucoma or Ocular Hypertension in Both Eyes. treatment 3 unknown_status NCT01881126
An Efficacy and Safety Study of Bimatoprost 0.01% Alone Compared With Travoprost 0.004% and Timolol 0.5% in Subjects With Glaucoma or Ocular Hypertension treatment 4 completed NCT03960866
Safety and Efficacy of Ophthalmic Phentolamine Mesylate in Glaucoma treatment 2 completed NCT03928665
Long-term Observation of Ophthalmic Changes in Patients With Obstructive Sleep Apnea No drug interventions Not Available Not Available active_not_recruiting NCT02558374
Double-masked Study of Netarsudil (AR-13324) Ophthalmic Solution in Subjects With Glaucoma or Ocular Hypertension treatment 3 completed NCT06267274
A Randomized, Double-blind, Parallel-group, Two-arm, Multiple Dose, Multicenter, Bioequivalence Study With Clinical Endpoint in the Treatment of Subjects With Chronic Open-angle Glaucoma or Ocular Hypertension in Both Eyes treatment 1 recruiting NCT01099774
Safety and Efficacy of Different Formulations of Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension treatment 3 completed NCT01297920
Three Month Efficacy/Safety Study With a 3-Month Safety Extension of Brinzolamide 1%/Brimonidine 0.2% vs. Brinzolamide 1% or Brimonidine 0.2% treatment 3 completed NCT01229982
A Study Evaluating the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open-Angle Glaucoma treatment 2 completed NCT03534882
Effects of Prostaglandin Analogue Washout Following Long-term Therapy in Adults With Primary Open Angle Glaucoma No drug interventions treatment Not Available completed NCT03850782
Evaluation of the Duration of Effect of Bimatoprost SR in Participants With Open-Angle Glaucoma or Ocular Hypertension treatment 3 active_not_recruiting NCT00372931
A Phase II Study of AL-37807 to Treat Open-Angle Glaucoma or Ocular Hypertension No drug interventions treatment 2 completed NCT01525173
A Safety and Efficacy Study of ALPHAGAN® P and LUMIGAN® in Subjects Previously Treated With Latanoprost for Glaucoma and Ocular Hypertension treatment 4 completed NCT01092273
Bimatoprost Versus Travoprost at Cairo University No drug interventions Not Available Not Available completed NCT02129673
A Phase 1/2 Multicenter, Randomized, Study to Evaluate the Safety and Efficacy of VS101 Subconjunctival Latanoprost Insert in Subjects With Open-Angle Glaucoma or Ocular Hypertension treatment 1 / 2 completed NCT02017327
Safety and Efficacy Assessment of Monoprost® in Comparison With Lumigan® 0.01 % and Lumigan® 0.03% Unit Dose treatment 4 completed NCT00372827
Study of Brinzolamide and Timolol When Added to Travoprost in Primary Open-angle Glaucoma or Ocular Hypertension treatment 4 completed NCT00503360
Tolerability, Safety and Efficacy of SAD448 in Subjects With Ocular Hypertension No drug interventions treatment 1 completed NCT01292460
Tafluprost-Timolol Preservative-free Fixed Dose Combination (FDC) Superiority Study Against Monotherapies No drug interventions treatment 3 completed NCT01342094
DE-111 Against Timolol Ophthalmic Solution 0.5% treatment 3 completed NCT00868894
Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension treatment 1 / 2 completed NCT00347191
Relationship Between Central Corneal Thickness and Intraocular Pressure Measures Instruments. No drug interventions Not Available Not Available completed NCT04202562
Efficacy and Safety of ab Interno Trabeculectomy With the Kahook Dual Blade No drug interventions treatment Not Available completed NCT00140062
Efficacy And Safety Of Xalatan Compared To Usual Care In Patients With Open Angle Glaucoma Or Ocular Hypertension. treatment 4 completed NCT00751062
A Study of Open Angle Glaucoma or Ocular Hypertension in Patients Within Scandinavia treatment 3 completed NCT02338362
Inhaled Corticosteroids: Effect on Intraocular Pressure in Patients With Controlled Glaucoma other 4 completed NCT01896180
Study to Compare the Safety and Efficacy of ALZ-1101 to Latanoprost in Patients With Intraocular Pressure Inadequately Controlled by Latanoprost treatment 2 completed NCT00273429
Cosopt Versus Xalatan treatment 4 completed NCT00887029
A 12 Week Comparison of DuoTrav and Xalacom in Open-Angle Glaucoma treatment 4 completed NCT04957329
Effect of Benzalkonium Chloride Preserved and Preservative-free Latanoprost Eye Drops on Conjunctival Goblet Cells treatment 4 recruiting NCT00143429
Corneal Versus Conjunctival Delivery Using a Delivery Device treatment 2 withdrawn NCT00680329
Glaucoma Adherence Study, Spain Not Available Not Available completed NCT03450629
Evaluation of Safety and Efficacy of PDP-716 treatment 3 completed NCT02083289
A 28 Day Study of ONO-9054 Ophthalmic Solution in Subjects With Ocular Hypertension (OHT) or Open-angle Glaucoma (OAG) treatment 2 completed NCT00846989
Efficacy, Tolerability and Safety of RKI983 (0.05% & 0.10%) vs Xalatan in Patients With POAG or Ocular Hypertension treatment 1 / 2 completed NCT03293992
A Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7058584 Following 7 Days of Instillation of Eye Drops in Patients With Primary Open Angle Glaucoma or Ocular Hypertension treatment 1 completed NCT00326092
A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension treatment 2 completed NCT01379144
A Study Comparing The Efficacy, Safety And Tolerability Of Latanoprost 75, 100 And 125 ug/ml To Xalatan In The Treatment Of Primary Open-Angle Glaucoma And Ocular Hypertension treatment 2 completed NCT01263444
Safety and Efficacy of Adding AZARGA® Adjunctive to Prostaglandin Therapy treatment 4 completed NCT01915940
Bimatoprost Ocular Insert Compared to Topical Timolol Solution in Patients With Glaucoma or Ocular Hypertension treatment 2 completed NCT06498440
Efficacy of NSAID vs. Steroid-NSAID Combo Post-Selective Laser Trabeculoplasty: Phase 4, Single-Center RCT treatment 4 not_yet_recruiting NCT01241240
Safety and Efficacy of Triple Combination Therapy in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension treatment 3 completed NCT05389267
Safety Assessment of T4090 Eye Drops in Ocular Hypertensive or Glaucomatous Patients. No drug interventions treatment 1 / 2 active_not_recruiting NCT01491867
Continuous Intraocular Pressure (IOP) Measurement and Ability to Detect Treatment Effect diagnostic Not Available completed NCT05857267
Dorzolamide+Timolol Multidose Preservative-free vs Dorzolamida+Timolol BAK Preserved Efficacy and Safety treatment 4 recruiting NCT03131167
Study of SHP639 Eye Drops in Adults With High Eye Pressure or Primary Open-angle Glaucoma No drug interventions treatment 1 completed NCT01415401
Efficacy and Tolerability of AZARGA® as Replacement Therapy in Patients on COMBIGAN® Therapy in Canada treatment 4 completed NCT00647101
A Study to Assess the Efficacy of 3 Months of Latanoprost Treatment in Reducing the Intraocular Pressure in Patients With Ocular Hypertension or Open-angle Glaucoma treatment 4 completed NCT03750201
A Study to Assess an Automated Laser Device for Direct Selective Laser Trabeculoplasty No drug interventions treatment Not Available completed NCT00538304
A Study of the Safety and Efficacy of Bimatoprost in Patients With Glaucoma or Ocular Hypertension treatment 2 completed NCT01254604
Preservative-Free Tafluprost (MK-2452) for the Treatment of Open-Angle Glaucoma or Ocular Hypertension (MK-2452-002) treatment 3 completed NCT01749904
Comparing Safety and Efficacy of BOL-303259-X With Timolol Maleate in Subjects With Open-Angle Glaucoma or Ocular Hypertension treatment 3 completed NCT05022004
A Therapeutic Equivalence Study in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension treatment 3 completed NCT01895972
Long-Term Safety of Latanoprostene Bunod Ophthalmic Solution 0.024% in Japanese Subjects With OAG or OHT treatment 3 completed NCT00332072
Safety and Efficacy Study of Bimatoprost/Timolol Fixed Combination in Patients Wtih Glaucoma or Ocular Hypertension treatment 3 completed NCT00753168
Phase 1-2 Evaluation of OT-730 Eye Drops in Reducing the Intraocular Pressure in Patients With Ocular Hypertension or Open-Angle Glaucoma treatment 1 / 2 completed NCT00051168
A Long-term Safety Study of Once-daily Travatan treatment 3 completed NCT00508469
Adherence Assessment With Travalert Dosing Aid treatment 4 completed NCT03762369
A Clinical Study to Evaluate the Efficacy and Safety of CKD-351 treatment 3 unknown_status NCT02358369
Dose-Ranging Study of the Bimatoprost Ocular Insert treatment 2 completed NCT01637246
A Study of Patients With Primary Open Angle Glaucoma or Ocular Hypertension Who Were Insufficiently Responsive to Monotherapy No drug interventions Not Available Not Available completed NCT00918346
Pharmacodynamics of Tafluprost 0.0015% Eye Drops: a Comparison Between the Preserved and Unpreserved Formulation treatment 3 completed NCT02250612
SYL040012, Treatment for Open Angle Glaucoma treatment 2 completed NCT02020512
A Study of 0.03% Bimatoprost in the Treatment of Primary Open Angle Glaucoma and Ocular Hypertension treatment 4 completed NCT01589510
A Study of Lumigan® 0.01% in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT) Not Available Not Available completed NCT00767481
1 Year Study Trav/Brinz QD Fixed Combination Versus COSOPT treatment 3 terminated NCT00273481
Cosopt Versus Xalacom treatment 4 completed NCT00822081
Comparison of the Fixed Combinations of Brimonidine/Timolol and Dorzolamide/Timolol in Subjects With Open-Angle Glaucoma or Ocular Hypertension treatment 4 completed NCT01342081
DE-111 Against Tafluprost Ophthalmic Solution 0.0015% Alone and Concomitant Use of Tafluprost Ophthalmic Solution 0.0015% Plus Timolol Ophthalmic Solution 0.5% treatment 3 completed NCT03901781
Study of ST266 Given by Intranasal Delivery in Glaucoma Suspect Subjects treatment 1 completed NCT00329095
An Evaluation of Use of Topical Ocular Hypotensive Medication by Compliance diagnostic 4 completed NCT00457795
24-hour IOP-lowering Effect of Brimonidine 0.1% treatment 4 completed NCT01628614
A Study of Intraocular Pressure (IOP) Reduction in Newly Diagnosed Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT) No drug interventions Not Available Not Available completed NCT04036214
Efficacy and Safety Outcomes of Optometrist Performed Selective Laser Trabeculoplasty (SLT) No drug interventions Not Available Not Available unknown_status NCT04284514
Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AKB-9778 Ophthalmic Solution treatment 1 completed NCT01735214
An Observational Study of Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT) Who Switched IOP-lowering Treatments No drug interventions Not Available Not Available completed NCT02278614
Efficacy and Safety Assessment of T2347 Versus Xalacom® in Ocular Hypertensive or Glaucomatous Patients treatment 3 completed NCT04695314
Foot Reflexology in Ocular Hypertensive and Glaucoma Patients No drug interventions prevention Not Available completed NCT01340014
Patient Preference Comparison of AZARGA Versus COSOPT treatment 4 completed NCT00334750
Distribution of Risk Factors in Ocular Hypertension and Open-Angle Glaucoma Patients in Canada No drug interventions Not Available Not Available completed NCT01430923
Clinical Evaluation of Safety and Efficacy of Refrigeration Free Latanoprost treatment Not Available unknown_status NCT03798223
Optimal Treatment Protocol for Selective Laser Trabeculoplasty No drug interventions treatment Not Available active_not_recruiting NCT01987323
Safety and Efficacy of Liposomal Latanoprost in Ocular Hypertension treatment 1 / 2 completed NCT00494923
Early Diagnosis, Pathogenesis and Progression of Open Angle Glaucoma No drug interventions Not Available Not Available unknown_status NCT00143208
Evaluation Of Intraocular Pressure Lowering-Effect Of Xalacom In Patients With Poag Or Oh. treatment 4 completed NCT02179008
Multi-center Phase II Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension treatment 2 completed NCT04630808
MRCT Evaluating NCX 470 vs. Latanoprost in Subjects With Open-Angle Glaucoma or Ocular Hypertension treatment 3 recruiting NCT04747808
Study of LL-BMT1 in Patients With Elevated Intraocular Pressure No drug interventions treatment 2 completed NCT05241938
PSLT Compared to Prostaglandin Analogue Eye Drops No drug interventions treatment Not Available unknown_status NCT02623738
A Study Assessing the Efficacy and Safety of DE-117 Ophthalmic Solution in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension -AYAME Study- treatment 2 / 3 completed NCT00300443
Safety and Efficacy Study of Bimatoprost in Patients With Glaucoma or Ocular Hypertension treatment 2 / 3 completed NCT00990743
Tolerance and Effect on Intraocular Pressure After Administration of SYL040012 treatment 1 completed NCT01481051
A Dose Evaluation Study for the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open-Angle Glaucoma treatment 2 completed NCT01481077
A Dose Evaluation Study of the Effect of Plug Placement on the Efficacy and Safety of the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open-Angle Glaucoma treatment 2 completed NCT04888156
Impact of Self-tonometry on Glaucoma Treatment Decision. No drug interventions Not Available Not Available completed NCT04064918
Effects of Netarsudil and Timolol on Retinal Blood Vessel Density and Visual Acuity No drug interventions other Not Available withdrawn NCT03931317
Study Comparing the Effects of Latanoprostene Bunod and Timolol on Retinal Blood Vessel Density and Visual Acuity other Not Available completed NCT04412096
Aqueous Humor Dynamic Components That Determine Intraocular Pressure Variance treatment 4 recruiting NCT02754570
The Diurnal and Nocturnal Effect of Pilocarpine on Intraocular Pressure and Ocular Perfusion Pressure treatment Not Available completed NCT03657797
Phase 2 Dose-Response Study Evaluating the Safety and Efficacy of NCX 470 vs Latanoprost in Subjects With Open-Angle Glaucoma or Ocular Hypertension treatment 2 completed NCT03532867
Study of Changes in Retrofoveolar Choroidal Thickness During Aerobic Exercise No drug interventions other Not Available unknown_status NCT02300818
Effects of Magnetic Therapy and Seawater Combined in Decreasing Intraocular Presion. No drug interventions treatment 1 / 2 unknown_status NCT01917383
A Phase II Study to Evaluate the Additivity of Trabodenoson to Latanoprost in Adults With Ocular Hypertension or Primary Open-Angle Glaucoma treatment 2 completed NCT01318252
AL-54478 Proof of Concept Study treatment 2 completed NCT02829996
Study of Fixed-Dose Combinations of Trabodenoson and Latanoprost in Adults With OHT or POAG treatment 2 completed NCT02565173
Study of Trabodenoson in Adults With Ocular Hypertension or Primary Open-angle Glaucoma treatment 3 completed NCT06249152
Qlaris Study of QLS-111 in Combination With a PGA for OAG and/or OHT Patients No drug interventions treatment 2 recruiting NCT01670266
Single and Multiple Dose Escalation and Two-sequence Crossover Study of ONO-9054 in Patients With Ocular Hypertension or Mild Open-angle Glaucoma treatment 1 completed NCT02226094
Safety and Efficacy of Deep Wave Trabeculoplasty (DWT) in Primary Open Angle Glaucoma and Ocular Hypertension No drug interventions treatment 1 / 2 terminated NCT01180062
Safety Study of Latanoprost Slow Release Insert treatment 1 terminated NCT06016972
Qlaris Phase 2 Study of QLS-111 in POAG and/or OHT Patients No drug interventions treatment 2 active_not_recruiting NCT04647461
Comparison of Efficacy and Ocular Surface Disease Assessment Between BRIDIN-T Eye Drops 0.15% and ALPHAGAN-P Eye Drops 0.15% in Glaucoma or Ocular Hypertensive Patients : Phase 4, Parallel Group Design, Investigator-blind, Active-control, Randomized, Multi-center Trial treatment 4 unknown_status NCT06078592
Comparison of Efficacy and Ocular Surface Assessment Between BRIDIN-plus and Combigan in Glaucoma or Ocular Hypertensive treatment 4 completed NCT01567761
The Effect of Two Different Artificial Respiration Methods on the Intraocular Pressure During Surgery Under General Anesthesia No drug interventions Not Available Not Available unknown_status